Clinical Trial: Examining Reward-Related Predictors and Mechanisms of Change in BA Treatment for Anhedonic Adolescents

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: Examining Reward-Related Predictors and Mechanisms of Change in BA Treatment for Anhedonic Adolescents

Brief Summary: The prevalence of major depressive disorder (MDD) is relatively low in childhood (i.e., 1-3%), but increases substantially during adolescence. By the age of 18, approximately 15% of adolescents will have experienced at least one episode of MDD. A growing body of research implicates abnormalities in reward circuitry as playing a critical role in the development and maintenance of depressive symptoms in adolescents. Importantly, these reward-circuitry abnormalities have been linked to anhedonia (i.e., decreased pleasure or blunted reactivity to rewarding stimuli). Behavioral Activation (BA) represents a promising - and relatively simple to deliver - nonpharmacologic intervention for adolescent depression, which has been shown to be at least as effective as Cognitive Behavioral Therapy (CBT) with regards to symptom reduction and lowering the risk of relapse in adult samples. More recently, promising data have emerged from the application of BA to depressed adolescents. BA can be conceptualized as a treatment directly targeting anhedonia. More specifically, BA targets anhedonia through behavioral change strategies aimed at gradually increasing patients' exposure to and engagement with rewarding stimuli and positively reinforcing experiences. Given this treatment focus, BA may be particularly beneficial for adolescents struggling with relatively elevated levels of anhedonic symptoms. Accordingly, the present study will examine the role of anhedonia and reward functioning in predicting treatment response in BA. In addition, analyses will be conducted examining the reward-related neural and behavioral mechanisms underlying anhedonic symptom improvement in BA.

Detailed Summary:

Participants in this research will include 35 anhedonic adolescents and 36 demographically matched healthy participants recruited from the greater Boston community by Dr. Webb at McLean Hospital's Center for Depression, Anxiety and Stress Research. The anhedonic adolescents will undergo 12 weeks of Behavioral Activation therapy. This study will include three sessions:

  • The first session will involve a diagnostic interview, and a series of questionnaires and assessments.
  • The second session will take place at the McLean Hospital's Neuroimaging Center, and involve an fMRI brain scan and administration of two behavioral tasks, as well as questionnaires.
  • Following the 12-weeks treatment, anhedonic adolescents will return to McLean Hospital's Neuroimaging Center for an fMRI brain scan, two behavioral tasks, and questionnaires. The healthy control group will complete the same three assessments at corresponding time points.

Sponsor: Mclean Hospital

Current Primary Outcome:

  • Change in anhedonic symptoms [ Time Frame: Change from pre-treatment (baseline) to post-treatment (12 weeks) ]
  • Change in brain activation during a monetary reward gambling task [ Time Frame: Change from pre-treatment (baseline) to post-treatment (12 weeks) ]
  • Change in performance on a probabilistic reward learning computer task [ Time Frame: Change from pre-treatment (baseline) to post-treatment (12 weeks) ]


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Mclean Hospital

Dates:
Date Received: July 10, 2015
Date Started: December 2015
Date Completion: January 2020
Last Updated: September 12, 2016
Last Verified: September 2016